Greylin Investment Mangement Inc Abbott Laboratories Transaction History

Greylin Investment Mangement Inc

$566 Million
Q2 2024

A detailed history of Greylin Investment Mangement Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Greylin Investment Mangement Inc holds 4,375 shares of ABT stock, worth $502,075. This represents 0.08% of its overall portfolio holdings.

Number of Shares

4,375

Previous 4,375 -0.0%

Holding current value

$502,075

Previous $497,000 8.65%

% of portfolio

0.08%

Previous 0.08%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 25, 2024	SELL	$90.19 - $110.4 $4,509 - $5,520	-50 Reduced 1.13%	4,375 $481,000
Q3 2023 Oct 10, 2023	SELL	$95.53 - $114.62 $19,106 - $22,924	-200 Reduced 4.32%	4,425 $428,000
Q4 2022 Jan 25, 2023	SELL	$95.06 - $111.52 $23,765 - $27,880	-250 Reduced 5.13%	4,625 $0
Q3 2022 Oct 13, 2022	SELL	$96.76 - $112.03 $4,838 - $5,601	-50 Reduced 1.02%	4,875 $472,000
Q2 2022 Jul 11, 2022	SELL	$102.07 - $123.37 $6,634 - $8,019	-65 Reduced 1.3%	4,925 $535,000
Q1 2022 May 20, 2022	SELL	$114.02 - $139.04 $5,701 - $6,952	-50 Reduced 0.99%	4,990 $591,000
Q3 2021 Oct 13, 2021	SELL	$116.66 - $129.06 $24,498 - $27,102	-210 Reduced 4.0%	5,040 $595,000
Q2 2021 Jul 14, 2021	SELL	$105.79 - $124.53 $10,579 - $12,453	-100 Reduced 1.87%	5,250 $609,000
Q4 2020 Jan 14, 2021	SELL	$105.0 - $114.42 $21,000 - $22,884	-200 Reduced 3.6%	5,350 $586,000
Q3 2020 Oct 13, 2020	SELL	$91.64 - $111.29 $123,714 - $150,241	-1,350 Reduced 19.57%	5,550 $604,000
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $35,222 - $45,080	460 Added 7.14%	6,900 $631,000
Q4 2019 Jan 09, 2020	SELL	$78.51 - $87.4 $111,876 - $124,545	-1,425 Reduced 18.12%	6,440 $559,000
Q3 2019 Oct 11, 2019	SELL	$81.84 - $88.74 $28,644 - $31,059	-350 Reduced 4.26%	7,865 $658,000
Q2 2019 Aug 15, 2019	SELL	$72.88 - $85.0 $200,420 - $233,750	-2,750 Reduced 25.08%	8,215 $691,000
Q1 2019 Apr 09, 2019	SELL	$66.22 - $80.06 $596,311 - $720,940	-9,005 Reduced 45.09%	10,965 $877,000
Q4 2018 Jan 14, 2019	SELL	$65.56 - $74.27 $1.11 Million - $1.26 Million	-16,946 Reduced 45.9%	19,970 $1.44 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $565,533 - $682,248	-9,300 Reduced 20.12%	36,916 $2.71 Million
Q2 2018 Aug 07, 2018	SELL	$57.57 - $63.54 $1,439 - $1,588	-25 Reduced 0.05%	46,216 $2.82 Million
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $7,877 - $8,906	-140 Reduced 0.3%	46,241 $2.77 Million
Q4 2017 Jan 16, 2018	SELL	$53.68 - $57.47 $16,104 - $17,241	-300 Reduced 0.64%	46,381 $2.65 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $2.24 Million - $2.5 Million	46,681	46,681 $2.49 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greylin Investment Mangement Inc, based on Form 13F filings with the SEC.

News

Stay updated on Greylin Investment Mangement Inc with notifications on news.

Account

Greylin Investment Mangement Inc Abbott Laboratories Transaction History